1. International Diabetes Federation. Global guideline for type 2 diabetes. 2012. http://www.idf.org/sites/default/files/IDF-Guideline-for-Type-2-Diabetes.pdf . Accessed 12 Oct 2015.
2. Ministry of Food and Drug Safety. MFDS approval of a new, domestically-developed, oral antihyperglycaemic agent [in Korean] [media release]. 2 Oct 2015. http://www.mfds.go.kr/index.do?mid=675&pageNo=1&seq=28999&cmd=v .
3. PipelineReview.com. Dong-A ST’s DPP4 inhibitor, SUGANON, got approved for type 2 diabetes in Korea. 2015. http://www.pipelinereview.com/index.php/2015100259148/Small-Molecules/Dong-A-STs-DPP4-inhibitor-SUGANON-got-approved-for-type-2-diabetes-in-Korea.html . Accessed 13 Oct 2015.
4. Dong-A ST. 2Q 2015 Performance Results. 2015. http://en.donga-st.com/B05.da?method=IRResourceList . Accessed 13 Oct 2015.
5. Dong-A ST. 2014 Annual report. 2015. http://en.donga-st.com/Pass.da?viewPath=/b05/IRReport . Accessed 13 Oct 2015.